Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Mar;27(3):337–339. doi: 10.1128/aac.27.3.337

Comparison of moxalactam and cefazolin as prophylactic antibiotics during cesarean section.

W Rayburn, M Varner, R Galask, C R Petzold, E Piehl
PMCID: PMC176272  PMID: 3994348

Abstract

Prophylactic antibiotics have been shown to be effective in decreasing the incidence of febrile morbidity associated with cesarean section after labor. However, the relative effectiveness of different single antibiotics has been studied infrequently, and these investigations have been limited by small patient samples. Several new, broad-spectrum antibiotics are now available, and any further benefit from more traditional antibiotics for surgical prophylaxis remains untested. A randomized prospective double-blind therapeutic trial was therefore undertaken to compare the value of a first-generation cephalosporin (cefazolin) with a new third-generation cephalosporin (moxalactam). Between July 1981 and June 1983, 254 qualifying women who underwent primary cesarean section after labor were randomly chosen for either of the two treatment groups. Although not statistically significant, the rates of febrile morbidity, wound infection, and endometritis were less for those treated with cefazolin (4.0, 3.2, and 0.8%, respectively) than for those treated with moxalactam (9.2, 7.7, and 1.6%, respectively). No serious adverse effects were apparent in the mother and newborn infant from short-term exposure to either drug. Although the newer, more expensive, and broader-spectrum cephalosporin, moxalactam, was associated with a low postoperative febrile morbidity rate and short postpartum hospitalization, it was no more beneficial than cefazolin.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apuzzio J. J., Reyelt C., Pelosi M., Sen P., Louria D. B. Prophylactic antibiotics for cesarean section: comparison of high- and low-risk patients for endomyometritis. Obstet Gynecol. 1982 Jun;59(6):693–698. [PubMed] [Google Scholar]
  2. Barza M., Tally F. P., Jacobus N. V., Gorbach S. L. In vitro activity of LY127935. Antimicrob Agents Chemother. 1979 Sep;16(3):287–292. doi: 10.1128/aac.16.3.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bottoms S. F., Rosen M. G., Sokol R. J. The increase in the cesarean birth rate. N Engl J Med. 1980 Mar 6;302(10):559–563. doi: 10.1056/NEJM198003063021006. [DOI] [PubMed] [Google Scholar]
  4. Cunningham F. G., Hauth J. C., Strong J. D., Kappus S. S. Infectious morbidity following cesarean section. Comparison of two treatment regimens. Obstet Gynecol. 1978 Dec;52(6):656–661. [PubMed] [Google Scholar]
  5. Cunningham F. G., Hemsell D. L., DePalma R. T., Kappus S., Roark M., Nobles B. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies. Am J Obstet Gynecol. 1981 Apr 15;139(8):915–921. doi: 10.1016/0002-9378(81)90958-3. [DOI] [PubMed] [Google Scholar]
  6. D'Angelo L. J., Sokol R. J. Short- versus long-course prophylactic antibiotic treatment in Cesarean section patients. Obstet Gynecol. 1980 May;55(5):583–586. [PubMed] [Google Scholar]
  7. Fainstein V., Bodey G. P., McCredie K. B., Keating M. J., Estey E. H., Bolivar R., Elting L. Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients. J Infect Dis. 1983 Oct;148(4):745–750. doi: 10.1093/infdis/148.4.745. [DOI] [PubMed] [Google Scholar]
  8. Fass R. J. In vitro activity of LY127935. Antimicrob Agents Chemother. 1979 Oct;16(4):503–509. doi: 10.1128/aac.16.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gall S. A. The efficacy of prophylactic antibiotics in cesarean section. Am J Obstet Gynecol. 1979 Jul 1;134(5):506–511. doi: 10.1016/0002-9378(79)90830-5. [DOI] [PubMed] [Google Scholar]
  10. Gibbs R. S., Blanco J. D., Duff P., Castaneda Y. S., St Clair P. J. A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery. Am J Obstet Gynecol. 1983 Aug 1;146(7):769–772. doi: 10.1016/0002-9378(83)91075-x. [DOI] [PubMed] [Google Scholar]
  11. Gordon H. R., Phelps D., Blanchard K. Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstet Gynecol. 1979 Feb;53(2):151–156. [PubMed] [Google Scholar]
  12. Joehl R. J., Rasbach D. A., Ballard J. O., Weitekamp M. R., Sattler F. R. Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection. Arch Surg. 1983 Nov;118(11):1259–1261. doi: 10.1001/archsurg.1983.01390110017004. [DOI] [PubMed] [Google Scholar]
  13. Kreutner A. K., Del Bene V. E., Delamar D., Bodden J. L., Loadholt C. B. Perioperative cephalosporin prophylaxis in cesarean section: effect on endometritis in the high-risk patient. Am J Obstet Gynecol. 1979 Aug 15;134(8):925–935. doi: 10.1016/0002-9378(79)90868-8. [DOI] [PubMed] [Google Scholar]
  14. Kreutner A. K., del Bene V. E., Delamar D., Huguley V., Harmon P. M., Mitchell K. S. Perioperative antibiotic prophylaxis is cesarean section. Obstet Gynecol. 1978 Sep;52(3):279–284. [PubMed] [Google Scholar]
  15. Morrison J. C., Coxwell W. L., Kennedy B. S., Schreier P. C., Wiser W. L., Fish S. A. The use of prophylactic antibiotics in patients undergoing cesarean section. Surg Gynecol Obstet. 1973 Mar;136(3):425–428. [PubMed] [Google Scholar]
  16. Rayburn W. F. Prophylactic antibiotics during cesarean section: an overview of prior clinical investigations. Clin Perinatol. 1983 Jun;10(2):461–472. [PubMed] [Google Scholar]
  17. Swartz W. H., Grolle K. The use of prophylactic antibiotics in cesarean section. A review of the literature. J Reprod Med. 1981 Dec;26(12):595–609. [PubMed] [Google Scholar]
  18. Thompson R. L., Wright A. J. Cephalosporin antibiotics. Mayo Clin Proc. 1983 Feb;58(2):79–87. [PubMed] [Google Scholar]
  19. Van der Auwera P., Clumeck N., Van Laethem Y., Vanhoof R., Butzler J. P. Moxalactam therapy of serious infections. Infection. 1983 Jul-Aug;11(4):212–218. doi: 10.1007/BF01641201. [DOI] [PubMed] [Google Scholar]
  20. Weissberg S. M., Edwards N. L., O'Leary J. A. Prophylactic antibiotics in cesarean section. Obstet Gynecol. 1971 Aug;38(2):290–293. [PubMed] [Google Scholar]
  21. Wong R., Gee C. L., Ledger W. J. Prophylactic use of cefazolin in monitored obstetric patients undergoing cesarean section. Obstet Gynecol. 1978 Apr;51(4):407–411. doi: 10.1097/00006250-197804000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES